Progressive Pulmonary Fibrosis
Progressive Pulmonary Fibrosis is a rare lung disease characterized by the gradual scarring of lung tissue, which can lead to difficulty breathing and reduced oxygen supply to the body.
Progressive Pulmonary Fibrosis: Inhaled Pirfenidone Study
We are testing an inhaled medication to see if it helps improve lung function and quality of life for people with Progressive Pulmonary Fibrosis. This study compares the medication to a placebo to assess its effects over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have any lung disease that affects your breathing, like pulmonary fibrosis or emphysema?
- Are you currently taking any medications for lung disease, such as nintedanib?
- Have you had any major changes in your lung health in the past month?
- Have you had any liver problems, like high liver enzymes or jaundice?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Blamonehel
Equitor
Esbriet
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Pneumomogy
Heverlee, Belgium
Centre hospitalier universitaire de Liege
Pneumology
Tilff, Belgium
Centre Hospitalier Regional D'Angers
Pneumology
Angers, France
Sponsor: Avalyn Pharma Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.